Lalit Bajaj
Concepts (334)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bronchiolitis | 8 | 2022 | 87 | 3.400 |
Why?
| | Emergency Service, Hospital | 61 | 2026 | 2357 | 3.240 |
Why?
| | Sepsis | 11 | 2025 | 668 | 2.100 |
Why?
| | Lactic Acid | 3 | 2017 | 295 | 1.310 |
Why?
| | Bacterial Infections | 2 | 2022 | 246 | 1.190 |
Why?
| | Appendicitis | 11 | 2022 | 150 | 1.140 |
Why?
| | Hospitals, Pediatric | 13 | 2025 | 561 | 1.120 |
Why?
| | Child | 79 | 2026 | 22638 | 1.110 |
Why?
| | Oxygen Inhalation Therapy | 4 | 2022 | 189 | 1.080 |
Why?
| | Analgesics, Opioid | 6 | 2022 | 1158 | 1.030 |
Why?
| | Epilepsy | 2 | 2020 | 397 | 0.860 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 3 | 2022 | 253 | 0.830 |
Why?
| | Fractures, Bone | 5 | 2021 | 431 | 0.820 |
Why?
| | Endocrine System Diseases | 3 | 2015 | 35 | 0.800 |
Why?
| | Emergencies | 4 | 2015 | 173 | 0.790 |
Why?
| | Pediatric Emergency Medicine | 2 | 2024 | 23 | 0.760 |
Why?
| | Infant | 34 | 2026 | 10093 | 0.760 |
Why?
| | Emergency Medical Services | 6 | 2019 | 680 | 0.700 |
Why?
| | Medical Overuse | 3 | 2024 | 30 | 0.700 |
Why?
| | Soft Tissue Infections | 1 | 2022 | 42 | 0.690 |
Why?
| | Chorioamnionitis | 1 | 2022 | 50 | 0.690 |
Why?
| | Mastitis | 1 | 2021 | 6 | 0.680 |
Why?
| | Craniocerebral Trauma | 3 | 2019 | 173 | 0.680 |
Why?
| | Acute Pain | 2 | 2021 | 58 | 0.680 |
Why?
| | Quality Improvement | 9 | 2026 | 1325 | 0.670 |
Why?
| | Gastroenteritis | 1 | 2022 | 63 | 0.670 |
Why?
| | Ketamine | 5 | 2017 | 141 | 0.660 |
Why?
| | Decision Support Systems, Clinical | 6 | 2025 | 277 | 0.660 |
Why?
| | Staphylococcal Infections | 2 | 2022 | 396 | 0.640 |
Why?
| | Infant, Newborn, Diseases | 1 | 2022 | 113 | 0.640 |
Why?
| | Home Care Services | 2 | 2022 | 290 | 0.640 |
Why?
| | Skin Diseases | 1 | 2022 | 144 | 0.630 |
Why?
| | Underage Drinking | 4 | 2021 | 22 | 0.600 |
Why?
| | Shock, Septic | 4 | 2025 | 230 | 0.600 |
Why?
| | Child, Preschool | 39 | 2026 | 11888 | 0.590 |
Why?
| | Humans | 96 | 2026 | 145625 | 0.580 |
Why?
| | Adolescent | 49 | 2026 | 22451 | 0.570 |
Why?
| | Pediatrics | 8 | 2026 | 1122 | 0.570 |
Why?
| | Metabolic Diseases | 2 | 2015 | 114 | 0.570 |
Why?
| | Retrospective Studies | 30 | 2025 | 17291 | 0.550 |
Why?
| | Plant Extracts | 1 | 2020 | 191 | 0.550 |
Why?
| | Cannabidiol | 1 | 2020 | 142 | 0.530 |
Why?
| | Anticonvulsants | 1 | 2020 | 251 | 0.520 |
Why?
| | Practice Patterns, Physicians' | 7 | 2022 | 1370 | 0.520 |
Why?
| | Medical Marijuana | 1 | 2019 | 119 | 0.510 |
Why?
| | Hospitalization | 8 | 2022 | 2468 | 0.500 |
Why?
| | Patient Admission | 2 | 2019 | 216 | 0.500 |
Why?
| | Multiple Organ Failure | 2 | 2022 | 122 | 0.480 |
Why?
| | Dronabinol | 1 | 2019 | 250 | 0.470 |
Why?
| | Anti-Bacterial Agents | 6 | 2025 | 1935 | 0.460 |
Why?
| | Hospital Mortality | 3 | 2022 | 1037 | 0.460 |
Why?
| | Capnography | 1 | 2015 | 16 | 0.460 |
Why?
| | Law Enforcement | 2 | 2026 | 52 | 0.450 |
Why?
| | Police | 2 | 2026 | 51 | 0.450 |
Why?
| | Oximetry | 1 | 2016 | 124 | 0.440 |
Why?
| | Male | 60 | 2026 | 73014 | 0.440 |
Why?
| | Health Care Costs | 1 | 2018 | 418 | 0.440 |
Why?
| | Infant, Newborn | 13 | 2022 | 6449 | 0.440 |
Why?
| | Airway Management | 1 | 2015 | 84 | 0.420 |
Why?
| | Female | 59 | 2026 | 79080 | 0.420 |
Why?
| | Fever | 2 | 2022 | 320 | 0.420 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2015 | 96 | 0.410 |
Why?
| | Asthma | 3 | 2022 | 1800 | 0.410 |
Why?
| | Clinical Laboratory Techniques | 2 | 2018 | 96 | 0.410 |
Why?
| | Patient Readmission | 3 | 2018 | 771 | 0.410 |
Why?
| | Electronic Health Records | 8 | 2025 | 1208 | 0.390 |
Why?
| | Prospective Studies | 21 | 2025 | 8087 | 0.380 |
Why?
| | Anesthetics, Dissociative | 3 | 2017 | 47 | 0.380 |
Why?
| | Triage | 1 | 2015 | 243 | 0.360 |
Why?
| | Patient Discharge | 4 | 2020 | 991 | 0.360 |
Why?
| | Intensive Care Units | 2 | 2015 | 923 | 0.350 |
Why?
| | Delivery of Health Care | 1 | 2018 | 942 | 0.340 |
Why?
| | Patient Transfer | 1 | 2015 | 223 | 0.340 |
Why?
| | Emergency Treatment | 4 | 2020 | 122 | 0.340 |
Why?
| | Disease Management | 1 | 2015 | 649 | 0.330 |
Why?
| | Ambulatory Care | 3 | 2021 | 627 | 0.330 |
Why?
| | Abdominal Pain | 6 | 2016 | 148 | 0.320 |
Why?
| | Guideline Adherence | 4 | 2020 | 585 | 0.310 |
Why?
| | Caregivers | 3 | 2017 | 1079 | 0.310 |
Why?
| | Sensitivity and Specificity | 9 | 2019 | 1992 | 0.310 |
Why?
| | United States | 16 | 2026 | 16041 | 0.300 |
Why?
| | Drug Prescriptions | 3 | 2022 | 290 | 0.300 |
Why?
| | Practice Guidelines as Topic | 5 | 2018 | 1581 | 0.290 |
Why?
| | Diagnostic Errors | 3 | 2022 | 178 | 0.290 |
Why?
| | Machine Learning | 3 | 2025 | 590 | 0.280 |
Why?
| | Risk Assessment | 6 | 2019 | 3678 | 0.280 |
Why?
| | Vomiting | 3 | 2008 | 131 | 0.280 |
Why?
| | Cohort Studies | 10 | 2020 | 6045 | 0.270 |
Why?
| | Ondansetron | 1 | 2008 | 19 | 0.270 |
Why?
| | Cannabis | 3 | 2021 | 519 | 0.270 |
Why?
| | Quality of Health Care | 3 | 2023 | 692 | 0.260 |
Why?
| | Head Injuries, Closed | 2 | 2018 | 49 | 0.260 |
Why?
| | Antiemetics | 1 | 2008 | 51 | 0.260 |
Why?
| | Cross-Sectional Studies | 13 | 2026 | 5875 | 0.250 |
Why?
| | Canada | 4 | 2024 | 430 | 0.250 |
Why?
| | Appendectomy | 5 | 2022 | 91 | 0.240 |
Why?
| | Pain Management | 2 | 2020 | 413 | 0.240 |
Why?
| | Home Care Services, Hospital-Based | 1 | 2006 | 9 | 0.240 |
Why?
| | Time Factors | 11 | 2020 | 7079 | 0.230 |
Why?
| | Registries | 6 | 2025 | 2382 | 0.230 |
Why?
| | Magnesium | 2 | 2020 | 155 | 0.230 |
Why?
| | Medical Audit | 1 | 2025 | 77 | 0.220 |
Why?
| | Hypnotics and Sedatives | 2 | 2006 | 221 | 0.210 |
Why?
| | Benchmarking | 1 | 2026 | 192 | 0.210 |
Why?
| | Spain | 2 | 2021 | 50 | 0.200 |
Why?
| | Intussusception | 1 | 2003 | 24 | 0.200 |
Why?
| | Length of Stay | 4 | 2025 | 1342 | 0.200 |
Why?
| | Enema | 1 | 2003 | 46 | 0.200 |
Why?
| | Orthopedic Procedures | 1 | 2006 | 252 | 0.200 |
Why?
| | Unnecessary Procedures | 1 | 2024 | 54 | 0.200 |
Why?
| | Anaphylaxis | 1 | 2005 | 105 | 0.190 |
Why?
| | Alcoholism | 2 | 2021 | 830 | 0.190 |
Why?
| | Acute Disease | 7 | 2020 | 1033 | 0.190 |
Why?
| | Metabolism, Inborn Errors | 1 | 2003 | 42 | 0.190 |
Why?
| | Intubation, Intratracheal | 2 | 2015 | 328 | 0.180 |
Why?
| | Critical Care | 2 | 2021 | 700 | 0.180 |
Why?
| | Tomography, X-Ray Computed | 6 | 2018 | 2766 | 0.180 |
Why?
| | Physical Examination | 2 | 2015 | 236 | 0.180 |
Why?
| | Prescription Drug Monitoring Programs | 1 | 2022 | 17 | 0.180 |
Why?
| | Drug Utilization | 3 | 2020 | 170 | 0.180 |
Why?
| | Brain Injuries, Traumatic | 2 | 2018 | 459 | 0.170 |
Why?
| | Communication Barriers | 2 | 2014 | 129 | 0.170 |
Why?
| | Prevalence | 2 | 2021 | 2852 | 0.170 |
Why?
| | Parental Consent | 1 | 2021 | 25 | 0.170 |
Why?
| | Musculoskeletal Pain | 1 | 2021 | 48 | 0.160 |
Why?
| | Follow-Up Studies | 5 | 2021 | 5397 | 0.160 |
Why?
| | Mass Screening | 2 | 2019 | 1300 | 0.160 |
Why?
| | Community-Acquired Infections | 1 | 2023 | 179 | 0.160 |
Why?
| | Substance-Related Disorders | 2 | 2021 | 1098 | 0.160 |
Why?
| | Antimicrobial Stewardship | 1 | 2023 | 136 | 0.160 |
Why?
| | Organ Dysfunction Scores | 2 | 2022 | 55 | 0.160 |
Why?
| | Diagnostic Imaging | 2 | 2014 | 340 | 0.150 |
Why?
| | Treatment Outcome | 8 | 2020 | 11744 | 0.150 |
Why?
| | Waiting Lists | 1 | 2022 | 242 | 0.150 |
Why?
| | Drug Hypersensitivity | 1 | 2021 | 93 | 0.150 |
Why?
| | Heuristics | 1 | 2019 | 11 | 0.150 |
Why?
| | Tracheostomy | 2 | 2015 | 136 | 0.150 |
Why?
| | Metabolic Clearance Rate | 1 | 2019 | 115 | 0.150 |
Why?
| | Half-Life | 1 | 2019 | 157 | 0.140 |
Why?
| | Advisory Committees | 1 | 2020 | 228 | 0.140 |
Why?
| | Biological Availability | 1 | 2019 | 146 | 0.140 |
Why?
| | First Aid | 1 | 2018 | 11 | 0.140 |
Why?
| | Tissue Distribution | 1 | 2019 | 334 | 0.140 |
Why?
| | Marijuana Abuse | 1 | 2021 | 215 | 0.140 |
Why?
| | Severity of Illness Index | 4 | 2015 | 2910 | 0.140 |
Why?
| | Time-to-Treatment | 2 | 2025 | 257 | 0.140 |
Why?
| | Hospitals | 2 | 2021 | 730 | 0.130 |
Why?
| | Attitude of Health Personnel | 1 | 2026 | 1212 | 0.130 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2018 | 104 | 0.130 |
Why?
| | Intensive Care Units, Neonatal | 1 | 2021 | 295 | 0.130 |
Why?
| | Global Health | 2 | 2015 | 402 | 0.130 |
Why?
| | Community Health Centers | 1 | 2018 | 59 | 0.130 |
Why?
| | Inpatients | 1 | 2022 | 538 | 0.130 |
Why?
| | Motivation | 1 | 2022 | 601 | 0.130 |
Why?
| | Incidence | 5 | 2019 | 2910 | 0.130 |
Why?
| | Healthcare Disparities | 3 | 2020 | 728 | 0.130 |
Why?
| | Veins | 1 | 2017 | 68 | 0.130 |
Why?
| | Oxygen | 1 | 2022 | 996 | 0.130 |
Why?
| | Bronchodilator Agents | 1 | 2018 | 186 | 0.130 |
Why?
| | Radiography, Thoracic | 1 | 2018 | 174 | 0.120 |
Why?
| | Intestinal Perforation | 1 | 2017 | 46 | 0.120 |
Why?
| | Staphylococcus aureus | 1 | 2021 | 458 | 0.120 |
Why?
| | Surveys and Questionnaires | 5 | 2024 | 6050 | 0.120 |
Why?
| | Inappropriate Prescribing | 1 | 2017 | 66 | 0.120 |
Why?
| | Tertiary Care Centers | 1 | 2018 | 194 | 0.120 |
Why?
| | Administration, Oral | 1 | 2019 | 867 | 0.120 |
Why?
| | Prognosis | 4 | 2022 | 4331 | 0.120 |
Why?
| | Algorithms | 2 | 2019 | 1843 | 0.120 |
Why?
| | Comorbidity | 1 | 2021 | 1652 | 0.120 |
Why?
| | Propofol | 1 | 2017 | 86 | 0.120 |
Why?
| | Anesthetics, Intravenous | 2 | 2015 | 67 | 0.120 |
Why?
| | Ultrasonography | 2 | 2018 | 788 | 0.120 |
Why?
| | Anemia, Sickle Cell | 1 | 2020 | 322 | 0.120 |
Why?
| | Ultrasonography, Doppler | 2 | 2014 | 122 | 0.120 |
Why?
| | Faculty, Medical | 1 | 2019 | 305 | 0.120 |
Why?
| | Laryngeal Masks | 1 | 2015 | 19 | 0.110 |
Why?
| | Arteries | 1 | 2017 | 260 | 0.110 |
Why?
| | Marijuana Smoking | 1 | 2019 | 248 | 0.110 |
Why?
| | Colorado | 7 | 2020 | 4588 | 0.110 |
Why?
| | Logistic Models | 5 | 2025 | 2112 | 0.110 |
Why?
| | Ambulatory Care Facilities | 1 | 2018 | 267 | 0.110 |
Why?
| | Larynx | 1 | 2015 | 56 | 0.110 |
Why?
| | Decision Support Techniques | 3 | 2017 | 473 | 0.110 |
Why?
| | Data Collection | 1 | 2018 | 647 | 0.110 |
Why?
| | Informed Consent | 1 | 2017 | 194 | 0.110 |
Why?
| | Virus Diseases | 1 | 2017 | 219 | 0.110 |
Why?
| | Spinal Fractures | 1 | 2015 | 81 | 0.110 |
Why?
| | Confidence Intervals | 2 | 2013 | 328 | 0.110 |
Why?
| | Hypotension | 1 | 2015 | 125 | 0.110 |
Why?
| | Morbidity | 1 | 2015 | 317 | 0.100 |
Why?
| | Analgesia | 2 | 2005 | 105 | 0.100 |
Why?
| | Elective Surgical Procedures | 1 | 2015 | 203 | 0.100 |
Why?
| | Body Temperature | 1 | 2015 | 227 | 0.100 |
Why?
| | International Classification of Diseases | 1 | 2015 | 142 | 0.100 |
Why?
| | Trachea | 1 | 2015 | 253 | 0.100 |
Why?
| | Burns | 1 | 2018 | 365 | 0.100 |
Why?
| | Blood Cell Count | 2 | 2013 | 56 | 0.100 |
Why?
| | Telephone | 2 | 2012 | 175 | 0.090 |
Why?
| | Patient Compliance | 1 | 2017 | 587 | 0.090 |
Why?
| | Cerebral Arterial Diseases | 1 | 2012 | 50 | 0.090 |
Why?
| | Patient Selection | 1 | 2017 | 720 | 0.090 |
Why?
| | Asymptomatic Diseases | 1 | 2013 | 102 | 0.090 |
Why?
| | Etomidate | 1 | 2012 | 21 | 0.090 |
Why?
| | Wounds, Nonpenetrating | 1 | 2015 | 304 | 0.090 |
Why?
| | Fibrin Fibrinogen Degradation Products | 1 | 2012 | 92 | 0.090 |
Why?
| | Age Factors | 2 | 2016 | 3321 | 0.090 |
Why?
| | Patient Care Team | 1 | 2018 | 700 | 0.090 |
Why?
| | Translating | 1 | 2012 | 46 | 0.090 |
Why?
| | Poisoning | 1 | 2013 | 119 | 0.090 |
Why?
| | Alcohol Drinking | 1 | 2019 | 847 | 0.090 |
Why?
| | Cost Savings | 1 | 2012 | 85 | 0.090 |
Why?
| | ROC Curve | 3 | 2022 | 613 | 0.080 |
Why?
| | Predictive Value of Tests | 3 | 2025 | 2097 | 0.080 |
Why?
| | Post-Concussion Syndrome | 1 | 2014 | 185 | 0.080 |
Why?
| | Statistics, Nonparametric | 1 | 2012 | 423 | 0.080 |
Why?
| | Heart Rate | 1 | 2015 | 844 | 0.080 |
Why?
| | Emergency Medicine | 2 | 2024 | 278 | 0.080 |
Why?
| | Brain Concussion | 2 | 2016 | 660 | 0.080 |
Why?
| | Blood Coagulation Disorders | 1 | 2012 | 190 | 0.080 |
Why?
| | Risk | 2 | 2012 | 917 | 0.080 |
Why?
| | Language | 2 | 2012 | 313 | 0.080 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2019 | 1403 | 0.080 |
Why?
| | Adult | 9 | 2026 | 40821 | 0.080 |
Why?
| | Intraocular Pressure | 1 | 2012 | 332 | 0.080 |
Why?
| | Fibrinolytic Agents | 1 | 2012 | 302 | 0.080 |
Why?
| | Reproducibility of Results | 5 | 2019 | 3396 | 0.070 |
Why?
| | Electrocardiography | 1 | 2013 | 666 | 0.070 |
Why?
| | Spinal Puncture | 1 | 2009 | 18 | 0.070 |
Why?
| | Infusions, Intravenous | 2 | 2010 | 429 | 0.070 |
Why?
| | Continuity of Patient Care | 1 | 2012 | 297 | 0.070 |
Why?
| | Diagnosis, Differential | 3 | 2012 | 1500 | 0.070 |
Why?
| | Bacteriological Techniques | 1 | 2009 | 66 | 0.070 |
Why?
| | Pregnancy | 1 | 2022 | 7217 | 0.070 |
Why?
| | Communication | 2 | 2019 | 979 | 0.070 |
Why?
| | Glasgow Coma Scale | 2 | 2017 | 211 | 0.070 |
Why?
| | Academic Medical Centers | 1 | 2012 | 560 | 0.070 |
Why?
| | Age Distribution | 1 | 2009 | 395 | 0.070 |
Why?
| | Critical Illness | 1 | 2015 | 905 | 0.070 |
Why?
| | Drug Overdose | 1 | 2013 | 376 | 0.070 |
Why?
| | Anti-Asthmatic Agents | 1 | 2010 | 263 | 0.070 |
Why?
| | Urinalysis | 2 | 2013 | 82 | 0.070 |
Why?
| | Biomarkers | 2 | 2016 | 4329 | 0.060 |
Why?
| | Venous Thromboembolism | 1 | 2011 | 330 | 0.060 |
Why?
| | United Kingdom | 2 | 2018 | 376 | 0.060 |
Why?
| | Chi-Square Distribution | 1 | 2008 | 511 | 0.060 |
Why?
| | Mental Disorders | 1 | 2016 | 1133 | 0.060 |
Why?
| | Anesthesia Recovery Period | 1 | 2006 | 28 | 0.060 |
Why?
| | Community Medicine | 1 | 2006 | 7 | 0.060 |
Why?
| | Fentanyl | 3 | 2015 | 126 | 0.060 |
Why?
| | Injections, Intramuscular | 1 | 2006 | 140 | 0.060 |
Why?
| | Recurrence | 2 | 2012 | 1125 | 0.060 |
Why?
| | Adrenergic Agonists | 1 | 2005 | 5 | 0.050 |
Why?
| | Potassium | 1 | 2005 | 151 | 0.050 |
Why?
| | Histamine H1 Antagonists | 1 | 2005 | 24 | 0.050 |
Why?
| | Feedback | 1 | 2025 | 180 | 0.050 |
Why?
| | Early Diagnosis | 1 | 2025 | 249 | 0.050 |
Why?
| | Attitude | 1 | 2006 | 253 | 0.050 |
Why?
| | Hemolysis | 1 | 2005 | 242 | 0.050 |
Why?
| | Fluid Therapy | 1 | 2005 | 152 | 0.050 |
Why?
| | Stroke | 1 | 2012 | 1283 | 0.050 |
Why?
| | Documentation | 1 | 2025 | 202 | 0.050 |
Why?
| | Hemoglobins | 1 | 2005 | 384 | 0.050 |
Why?
| | Radiography | 2 | 2015 | 856 | 0.050 |
Why?
| | Double-Blind Method | 1 | 2008 | 2064 | 0.050 |
Why?
| | Fasting | 1 | 2004 | 280 | 0.050 |
Why?
| | Blood Specimen Collection | 1 | 2002 | 37 | 0.040 |
Why?
| | Midazolam | 2 | 2015 | 69 | 0.040 |
Why?
| | Feasibility Studies | 1 | 2025 | 1125 | 0.040 |
Why?
| | Penicillins | 1 | 2021 | 65 | 0.040 |
Why?
| | Neutrophils | 2 | 2016 | 1132 | 0.040 |
Why?
| | Glucocorticoids | 1 | 2005 | 536 | 0.040 |
Why?
| | Prescriptions | 1 | 2020 | 74 | 0.040 |
Why?
| | National Institute on Alcohol Abuse and Alcoholism (U.S.) | 1 | 2019 | 1 | 0.040 |
Why?
| | Delayed Diagnosis | 1 | 2020 | 102 | 0.040 |
Why?
| | Survival Rate | 1 | 2005 | 2078 | 0.040 |
Why?
| | Case-Control Studies | 2 | 2022 | 3633 | 0.040 |
Why?
| | Drug Therapy, Combination | 2 | 2017 | 1034 | 0.040 |
Why?
| | Critical Pathways | 1 | 2020 | 104 | 0.040 |
Why?
| | Administration, Intravenous | 1 | 2020 | 172 | 0.040 |
Why?
| | Non-Randomized Controlled Trials as Topic | 1 | 2018 | 20 | 0.040 |
Why?
| | Reference Values | 2 | 2014 | 787 | 0.040 |
Why?
| | Wales | 1 | 2018 | 24 | 0.040 |
Why?
| | Qualitative Research | 1 | 2026 | 1720 | 0.030 |
Why?
| | Abdomen, Acute | 1 | 2018 | 20 | 0.030 |
Why?
| | Information Dissemination | 1 | 2020 | 224 | 0.030 |
Why?
| | Portugal | 1 | 2017 | 5 | 0.030 |
Why?
| | Interprofessional Relations | 1 | 2020 | 274 | 0.030 |
Why?
| | Ireland | 1 | 2017 | 33 | 0.030 |
Why?
| | Quality Control | 1 | 2018 | 162 | 0.030 |
Why?
| | Outpatients | 1 | 2021 | 437 | 0.030 |
Why?
| | Research | 1 | 2021 | 421 | 0.030 |
Why?
| | New Zealand | 1 | 2017 | 56 | 0.030 |
Why?
| | Needs Assessment | 1 | 2020 | 403 | 0.030 |
Why?
| | Costs and Cost Analysis | 1 | 2018 | 216 | 0.030 |
Why?
| | Australia | 1 | 2017 | 291 | 0.030 |
Why?
| | Lymphocyte Count | 1 | 2016 | 166 | 0.030 |
Why?
| | Emotional Adjustment | 1 | 2016 | 18 | 0.030 |
Why?
| | Program Evaluation | 1 | 2020 | 945 | 0.030 |
Why?
| | Risk Factors | 3 | 2019 | 10840 | 0.030 |
Why?
| | Leukocyte Count | 1 | 2016 | 319 | 0.030 |
Why?
| | Area Under Curve | 1 | 2016 | 333 | 0.030 |
Why?
| | Neuromuscular Nondepolarizing Agents | 1 | 2015 | 34 | 0.030 |
Why?
| | Androstanols | 1 | 2015 | 30 | 0.030 |
Why?
| | Medical Order Entry Systems | 1 | 2015 | 40 | 0.030 |
Why?
| | Laryngoscopy | 1 | 2015 | 122 | 0.030 |
Why?
| | Pilot Projects | 1 | 2019 | 1878 | 0.020 |
Why?
| | Clinical Enzyme Tests | 1 | 2013 | 9 | 0.020 |
Why?
| | Salicylates | 1 | 2013 | 29 | 0.020 |
Why?
| | Students | 1 | 2019 | 647 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2016 | 1531 | 0.020 |
Why?
| | Respiratory Tract Infections | 1 | 2017 | 399 | 0.020 |
Why?
| | Time Management | 1 | 2012 | 20 | 0.020 |
Why?
| | Blood Chemical Analysis | 1 | 2013 | 109 | 0.020 |
Why?
| | Injury Severity Score | 1 | 2014 | 571 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2013 | 494 | 0.020 |
Why?
| | Pandemics | 1 | 2020 | 1700 | 0.020 |
Why?
| | Recovery of Function | 1 | 2016 | 721 | 0.020 |
Why?
| | Neuropsychological Tests | 1 | 2016 | 1136 | 0.020 |
Why?
| | Acetaminophen | 1 | 2013 | 268 | 0.020 |
Why?
| | North America | 1 | 2010 | 299 | 0.020 |
Why?
| | Parents | 1 | 2018 | 1393 | 0.020 |
Why?
| | Health Care Surveys | 1 | 2010 | 538 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2016 | 3005 | 0.020 |
Why?
| | Patient Satisfaction | 1 | 2012 | 698 | 0.020 |
Why?
| | Young Adult | 2 | 2017 | 14240 | 0.020 |
Why?
| | Seizures, Febrile | 1 | 2006 | 23 | 0.010 |
Why?
| | Potassium Acetate | 1 | 2005 | 1 | 0.010 |
Why?
| | Infusions, Parenteral | 1 | 2005 | 47 | 0.010 |
Why?
| | Respiration Disorders | 1 | 2004 | 78 | 0.010 |
Why?
| | Respiratory Tract Diseases | 1 | 2005 | 178 | 0.010 |
Why?
| | Linear Models | 1 | 2005 | 847 | 0.010 |
Why?
| | Analgesics | 1 | 2005 | 231 | 0.010 |
Why?
| | Middle Aged | 2 | 2019 | 36359 | 0.010 |
Why?
| | Cardiovascular Diseases | 1 | 2005 | 2218 | 0.010 |
Why?
|
|
Bajaj's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|